Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.04. | PMD Device Solutions Signs Transfer Agreement for Key Assets in Coala-Life Group AB to Accelerate its US Market Entry | 346 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) ("PMDS") today announced it has signed a transfer agreement with the Trustee of Coala-Life Group AB ("Coala... ► Artikel lesen | |
11.04. | Update to Closure Date for the Transfer Agreement Between PMD Device Solutions and Coala-Life Group AB | 196 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMDS and the Trustee of Coala-Life Group AB Estate will extend the closing date to April 12th.PMDS and the... ► Artikel lesen | |
09.04. | PMD Device Solutions Intends to Acquire Key Assets in Coala-Life Group AB to Accelerate its US Market Entry | 378 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 9, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions ("PMDS") today announced it intends to enter a transfer agreement with the Trustee of Coala-Life... ► Artikel lesen | |
03.04. | Bulletin from the Extraordinary General Meeting of PMD Device Solutions AB held on 3 April 2024 | 315 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / April 3, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (publ), held an extraordinary general meeting on Wednesday, 3 April 2024. The main resolutions... ► Artikel lesen | |
28.03. | PMD Device Solutions: Rett Syndrome Research Trust selects PMD Solutions' RespiraSense In Their Upcoming US-Based Biosensor Validation Study - VIBRANT | 185 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / March 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions (PMDS). RSRT's upcoming... ► Artikel lesen | |
25.03. | PMD Device Solutions Begins Preparation for First German Hospital Pilot | 262 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / March 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) A leading 1,100-bed hospital in Bavaria commences IT governance ahead of their first patient use of RespiraSense... ► Artikel lesen | |
15.03. | Notice of Extraordinary General Meeting in PMD Device Solutions AB | 345 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / March 15, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The shareholders of PMD Device Solution AB (publ), reg. no. 556639-6809 ("PMD" or the "Company"), are hereby invited... ► Artikel lesen | |
04.03. | Redeye Initiates Coverage of PMD Device Solutions | 322 | ACCESSWIRE | STOCKHOLM, SE / ACCESSWIRE / March 04, 2024 / PMD Device Solutions (STO:PROMO) (FRA:8T0) Redeye assigns a base-case valuation of SEK 18 per shareRedeye initiates coverage of PMDS today with a base-case... ► Artikel lesen | |
29.02. | PMD Device Solutions: PMDS: Year-end Report April-December 2023 | 325 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / February 29, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) Press release: Stockholm, 29 February 2024. PMD Device Solutions AB's (PMDS) Year-end report for April... ► Artikel lesen | |
31.01. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 31.01.2024 | 387 | Xetra Newsboard | The following instruments on XETRA do have their first trading 31.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 31.01.2024
Aktien
1 AU0000241416 Toubani Resources Ltd.
2... ► Artikel lesen | |
30.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.01.2024 | 656 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 30.01.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.01.2024ISIN NameCA48214J1093 JUST... ► Artikel lesen | |
30.01. | XFRA ISIN CHANGE | 436 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA65654L1058 Norseman Silver Inc. 30.01.2024 CA33827E1016 Fitzroy Minerals Inc. 31.01.2024 Tausch 1:1SE0009947740 PMD... ► Artikel lesen | |
30.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.01.2024 | 278 | Xetra Newsboard | Das Instrument C3Y3 CA65654L1058 NORSEMAN SILVER INC. EQUITY wird cum Kapitalmassnahme gehandelt am 30.01.2024 und ex Kapitalmassnahme am 31.01.2024 The instrument C3Y3 CA65654L1058 NORSEMAN SILVER... ► Artikel lesen | |
29.01. | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for PMD Device Solutions AB (41/24) | 278 | GlobeNewswire | Referring to the bulletin from PMD Device Solutions AB's annual general
meeting, held on December 29, 2023, the company will carry out a reverse stock
split in relations 1:128. The share will be traded... ► Artikel lesen | |
29.01. | PMD Device Solutions: PMD Announces New ISIN Code and Timetable for Reverse Split of Shares | 258 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / January 29, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) In connection with the reverse share split, whereby 128 shares are combined into one (1) new share, PMDS... ► Artikel lesen | |
25.01. | PMD Device Solutions: RespiraSense Selected by an Industry-Leading Ventilation Company for Clinical Studies | 351 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / January 25, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) In Q1 2024, a market-leading ventilation company commences three separate clinical studies aimed at improving... ► Artikel lesen | |
25.01. | PMD Device Solutions: PMD Informs About the Record Date and Procedure of Reverse Split of Shares | 275 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / January 25, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) At PMD's General Meeting on December 29, 2023, it was resolved, in accordance with the Board's proposal... ► Artikel lesen | |
16.01. | Promore Pharma: PMD Updates on the Reverse Share Split Following the Reverse Acquisition | 440 | ACCESSWIRE | STOCKHOLM, SWEDEN / ACCESSWIRE / January 16, 2024 / Promore Pharma (STO:PROMO)(FRA:8T0) PMD Device Solutions AB ("PMD" or the "Company") formerly Promore Pharma AB, carried out the reverse acquisition... ► Artikel lesen | |
16.01. | Nasdaq Stockholm AB: Change of company name for Promore Pharma AB (28/24) | 277 | GlobeNewswire | Commencing January 17, 2024, Promore Pharma AB shares will be traded under its
new name, PMD Device Solutions AB.
New company name: PMD Device Solutions AB
---------------------------------------------
New... ► Artikel lesen | |
11.01. | Nasdaq Stockholm AB: The observation status for Promore Pharma AB (under name change to PMD Device Solutions AB) is removed (14/24) | 343 | GlobeNewswire | On June 28, 2023, the shares in Promore Pharma AB (under name change to PMD
Device Solutions AB) (the "Company") were given observation status with
reference to that the Company had, on the one hand... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 53,00 | +1,61 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
RXSIGHT | 54,92 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
NEWGENIVF GROUP | 2,230 | 0,00 % | NewGenIVF Limited: NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings | BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 23,000 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
FRESENIUS | 27,820 | +0,58 % | DAX-Check LIVE: Adidas, Continental, Covestro, Fresenius, Infineon, Porsche AG im Fokus | Dem DAX gelang es gestern nicht sich aus der Minuszone herauszuarbeiten. Er ging mit einem Verlust von 1,44 Prozent aus dem Handel. Damit schloss er bei 17.766 Punkten. Worauf es jetzt für den DAX ankommt... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,800 | 0,00 % | Where Privia Health Gr Stands With Analysts | ||
CARL ZEISS MEDITEC | 101,60 | -0,97 % | Carl Zeiss Meditec: Risiken bei der Prognose | Am 8. Mai wird Carl Zeiss Meditec Zahlen zum zweiten Quartal publizieren. Die Analysten der Deutschen Bank rechnen beim Umsatz mit einem organischen Rückgang um 1 Prozent. Das EBIT soll um 27 Prozent... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 53,75 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
GERRESHEIMER | 102,00 | 0,00 % | Gerresheimer: Aktie im Aufwind - das steckt dahinter | Das Analystenhaus Stifel hat am Mittwoch seine Einschätzung zur Gerresheimer-Aktie erneuert und spricht nun eine klare Kaufempfehlung aus. Die Aktie ist am Vormittag stark gefragt und gehört zu den... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,640 | -0,65 % | FMC: Erfolge werden deutlicher | Fresenius Medical Care (FMC) erwirtschaftet derzeit rund 70 Prozent des Umsatzes in den USA. Dabei ist das dortige Geschäft überdurchschnittlich profitabel für FMC. Sollte es in dem Land zu Steuersenkungen... ► Artikel lesen | |
PROGYNY | 32,370 | 0,00 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
ATRICURE | 23,150 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
LIFESTANCE HEALTH GROUP | 6,110 | 0,00 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 | ||
ADAPTHEALTH | 9,795 | 0,00 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
LIFEMD | 10,890 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2023 Results | Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago... ► Artikel lesen |